Abstract:Background: Although positive airway pressure (PAP) therapy is considered first-line treatment for obstructive sleep apnea (OSA), non-adherence is common. Numerous factors influence PAP use, including a belief that the therapy is important and effective. In theory, providing information to patients about their blood oxygen levels during sleep, which may be low when PAP is not used, juxtaposed to information about their PAP use may influence a patient's beliefs about therapy and increase PAP use. With the advent of consumer wearable smartwatches' blood oxygen saturation monitoring capability (and the existing routine availability of PAP use data transmitted via modem to clinical dashboards), there is an opportunity to provide this combination of information to patients. Objective: The Chronic care management with wearable devices in patients prescribed Positive Airway Pressure therapy (mPAP) study is a pilot randomized waitlist-controlled trial testing the feasibility, acceptability, and preliminary efficacy of a program that augments current PAP therapy data with consumer-grade wearable device to promote self-management of PAP therapy for OSA. Methods: Single-blinded randomized controlled trial. We will randomize 50 individuals with a history of OSA who receive care from a Department of Veterans Affairs medical center in the Los Angeles area and are nonadherent to prescribed PAP therapy to Immediate intervention or Waitlist control. During a 28-day intervention, the participants will wear a study-provided consumer wearable device and complete a weekly survey about their OSA symptoms. A report that summarizes consumer wearable-provided oxygen saturation values, PAP use derived from modem data, and patient-reported OSA symptoms will be prepared weekly and shared with the patient. Immediate intervention group will begin intervention immediately after randomization (T1). Assessments will occur at week 5 (T3; one-week post-treatment for Immediate intervention group and repeat baseline for Waitlist control group) and week 11 (T5; follow-up for Immediate intervention group and one-week post-treatment for Waitlist control group). The primary outcome will be the change in 7-day PAP adherence (average minutes/night) from T1 to T3. The primary analysis will be a comparison of the primary outcome between the Immediate intervention and the Waitlist control groups (intention-to-treat design), using a two-sample t-test on change scores (unadjusted). Results: Recruitment began in October 2023. Data analysis is expected to begin in October 2024 when all follow-ups are complete, and a manuscript summarizing trial results will be submitted following completion of data analysis. Conclusions: Findings from the study may provide additional insights on how patients with OSA might use patient-generated health data collected by consumer wearables to inform self-management of OSA, and possibly increase their use of PAP therapy. Clinicaltrial: ClinicalTrials.gov NCT06039865.

1056 Medical Record Alert to Increase PAP Use in Hospitalized Patients on Home PAP for Sleep Disordered Breathing

0543 The Utility of the PAP NAP for Increasing Patient Utilization of Positive Airway Pressure Therapy

0574 An Intervention to Promote Positive Airway Pressure (PAP) Use: Qualitative Analysis of Barriers and Facilitators

Effect of telemonitoring and as-needed patient support on positive airway pressure therapy adherence

1052 Impact of CPAP Adherence on Hospitalized Patients Diagnosed with OSA on Healthcare Utilization in Rural Settings

0565 Utilization of Pap Titration as Indicator for Prediction of Pap Adherence

Effects of Mask Change/Renewal on Adherence to Positive Airway Pressure Therapy: Analysis of a Large Telemedicine Database

0537 Enhancing PAP Adherence in Black and Hispanic Patients Utilizing an Automated Telemonitoring Intervention

Positive Airway Pressure Adherence and Health Care Resource Utilization in Patients With Obstructive Sleep Apnea and Heart Failure With Reduced Ejection Fraction

Adherence to long-term non-invasive positive airway pressure therapy

0573 Morning Questionnaire Post-PAP Titration as a Prediction Tool of Early PAP Adherence

Pilot study of positive airway pressure usage, patient journey and program engagement for users of a digital obstructive sleep apnea program

0538 Healthcare Resource Utilization in Treated Obstructive Sleep Apnea Patients with Comorbid Insomnia

Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term

Peer-Driven Intervention for Care Coordination and Adherence Promotion for Obstructive Sleep Apnea: A Randomized, Parallel-Group Clinical Trial

Telemedicine-based proactive patient management during positive airway pressure therapy: Impact on therapy termination rate

Intensive support does not improve PAP use in Spinal Cord injury/disease: A randomized clinical trial

Correlation between positive airway pressure and medication adherence: the healthy user effect

Testing a consumer wearables program to promote use of positive airway pressure therapy in patients with obstructive sleep apnea: protocol for a pilot randomized controlled trial

Reducing the receipt of contraindicated medications in patients with Parkinson disease

1051 A Novel Sleep Pilot Program to Streamline Care in Patients Undergoing Joint Replacement